To view all features and options, click here.
A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.
There are fewer than 10 vaccine manufacturers in Africa, based across Egypt, Morocco, Tunisia, Senegal and South Africa, according to the World Health Organisation. And most of those carry out packaging and labeling rather than manufacturing. That makes the continent ill-equipped to source and supply doses in times of crisis, as this pandemic has demonstrated.
âThe only way to ensure vaccine equity is to produce more vaccines where they are needed,â Rwanda President Paul Kagame said this week. âSo long as Africa remains dependent on other regions for vaccines, we will always be at the back of the queue whenever there is scarcity.â
Pfizer plans to ship 4.5 million vaccine doses to South Africa by June
Updated May 02, 2021;
Pfizer Inc. will ship 4.5 million doses of its COVID-19 vaccines to South Africa by June helping the nation ramp up its inoculation drive.
The first 325,260 doses will arrive Sunday night, Zweli Mkhize, South Africa’s health minister said in a statement. The government also expects Johnson & Johnson to release stock from the Aspen Pharmacare Holdings Ltd.’s plant in the nation by the middle of May following a verification process with regulators, according to the statement. Aspen is making the J&J vaccines under license.
South Africa, which is the worst-affected country by the coronavirus pandemic on the continent, lags behind emerging market peers in vaccinations. It halted J&J vaccines after health agencies last month called for their suspension in the U.S. The J&J shot is a key element to the nation’s vaccination plan and has already been used to inoculate health workers, with n
India Covid Cases Slow; Thai Death Toll at Record: Virus Update Bloomberg 1 hr ago
(Bloomberg)
Prime Minister Narendra Modi has lost a crucial election as India’s Covid crisis deepens, with an official in his Bharatiya Janata Party conceding defeat in the populous state of West Bengal. Modi had been widely criticized for continuing to hold mass rallies in the state as infections rose.
Talks starting this week between the U.S. and the World Trade Organization over expanding access to vaccines will focus on how to get them “widely distributed, more widely licensed, more widely shared,” according to White House Chief of Staff Ron Klain. U.S. cases dropped to 45,236, the fewest on a Saturday since late September.
Hong Kong Test Record; U.S. to Start WTO Talks: Virus Update Bloomberg 1 hr ago
(Bloomberg)
Talks starting this week between the U.S. and the World Trade Organization over expanding access to vaccines will focus on how to get them “widely distributed, more widely licensed, more widely shared,” according to White House Chief of Staff Ron Klain. U.S. cases dropped to 45,236, the fewest on a Saturday since late September.
India’s deepening Covid-19 crisis cost Prime Minister Narendra Modi in a key election, as the ruling BJP party conceded West Bengal’s state poll. Modi had been widely criticized for continuing to hold mass rallies in the state in as infections rose.
By Mike Cohen
(Bloomberg) – South Africa said a delivery of 1.1 million Johnson & Johnson coronavirus vaccines has been delayed pending further safety checks, the latest blow to the country’s stop-start inoculation program.
The government ordered 31 million of J&J’s single-dose shots and planned to begin issuing them to people over the age of 60 starting May 17. The doses are ready to be issued by Durban-based drugmaker Aspen Pharmacare Holdings Ltd., which has a deal with J&J to complete the final stage of production, but they won’t now be delivered by early this week as previously expected.
Instead, a protracted safety verification process has to be undertaken in conjunction with international regulatory agencies, Health Minister Zweli Mkhize said in a statement Sunday. The precaution was taken following a production glitch at a plant operated by Emergent BioSolutions Inc. in the U.S., where materials for J&J shots were mixed with those used in doses developed by U.K. dr